Acute Kidney Injury
Chronic kidney disease, ventilator use, hypoalbuminemia, and higher mean arterial pressure increase the likelihood of withdrawal from renal replacement therapy for acute kidney injury.
A large retrospective study found that the acid-suppressing medications increase the risk of acute kidney injury and chronic kidney disease.
Individuals taking more than 7 defined daily doses of NSAIDs each month had 20% greater risks of acute kidney injury and chronic kidney disease than those taking none.
Prolonged intermittent renal replacement therapy may eliminate as much as half of the daily dose of colistin in patients who are critically ill.
In a large study, older age, black race, Hispanic ethnicity, anemia, decreased renal function, and cardiovascular comorbidities emerged as independent predictors of recurrent acute kidney injury.
Hospitalized men and women in the highest quartile of serum uric acid had a 3-fold higher risk of acute kidney injury than those in the lowest quartile.
Elevated calcium-phosphate product at hospital admission is associated with an increased risk of acute kidney injury.
Higher incidence seen for in-hospital mortality, acute respiratory failure, acute kidney injury.
In a meta-analysis, the risks for premature death nearly doubled, CKD nearly tripled, and ESRD nearly quintupled after an episode of acute kidney injury.
In a study, nearly 1 in 10 cancer patients on systemic therapy experienced an episode of acute kidney injury.
The risk of post-contrast acute kidney injury increased with decreasing renal function.
Two molecular sub-phenotypes perform differently in response to vasopressin therapy.
In a Canadian study of patients who experienced AKI during hospitalization, treatment with an ACEI or ARB within 6 months of discharge was associated with a 15% lower risk for death after 2 years.
In a propensity score-matched analysis, AKI was associated with a 3.4-fold greater risk of dementia.
Statin use vs non-use among patients hospitalized with dialysis-requiring acute kidney injury is associated with decreased risks of 1-year and in-hospital all-cause mortality, a study found.
Individuals with a serum bicarbonate level below 24 mEq/L have a 2-fold increased risk of AKI compared with those with a level of 25-28 mEq/L.
More than half of patients died prematurely, regardless of whether they received early or delayed RRT.
Use of ultra-low contrast volume during percutaneous coronary intervention was associated with 32% decreased odds of acute kidney injury, investigators report.
Stage 1 acute kidney injury accounted for the biggest growth in incidence rate.
Serum uric acid levels above the median prior to cardiac surgery is independently associated with 5.5-fold increased odds of postoperative acute kidney injury.
Sodium bicarbonate infusions decreased the risk of death or organ failure among ICU patients with acute kidney injury and severe metabolic acidemia.
Proteinuria at the time of surgery is associated with an elevated risk of postoperative acute kidney injury and 30-day unplanned readmission.
Reduced kidney injury, better kidney function seen after prolonged cardiopulmonary bypass.
According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using the FAERS database.
For hospitalized patients, risk also increased for those receiving 3 or more CNS antidepressants.
If the study findings are confirmed, earlier detection of heart failure could save lives, according to researchers.
Early acetaminophen exposure after pediatric cardiac surgery may reduce rate of acute kidney injury.
Fluid restriction has no impact on disability-free survival; increases risk of acute kidney injury
Cystatin C as biomarker, kidney function marker linked to 20-year cumulative incidence of HI.
Investigators report that female vs male sex was associated with a significant 14% lower mortality risk following an episode of community-acquired acute kidney injury.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)